Number of the records: 1  

From migraine mechanisms to innovative therapeutic drugs

  1. SYSc032107
    LBL
      
    ^^^^^nam^^22^^^^^^^^450^
    005
      
    20060310121938.0
    100
      
    $a 20050701d2005 m y0sloc0103 ba
    101
    0-
    $a eng
    102
      
    $a US
    105
      
    $a a rz 000yy
    200
    1-
    $a From migraine mechanisms to innovative therapeutic drugs $f guest ed. Nabih M. Ramadan
    210
      
    $a Hagerstown, Md. $c Lippincott Williams & Wilkins $d 2005
    215
      
    $a S25 s. $c il., obr., grafy
    225
    2-
    $a Neurology $v suppl. 2 $x 0028-3878
    320
      
    $a Obsahuje bibliografické odkazy
    541
    1-
    $a Od mechanizmov migrény po inovačné terapeutické látky
    606
    1-
    $3 sllk_un_auth*d008881 $a migréna $x patofyziológia $x farmakoterapia $9 . $2 mesh
    606
    1-
    $3 sllk_un_auth*d000894 $a antiflogistiká nesteroidné $x farmakokinetika $9 . $2 mesh
    606
    1-
    $3 sllk_un_auth*d017366 $a agonisty serotonínových receptorov $x farmakokinetika $9 . $2 mesh
    606
    2-
    $a farmakoterapia kombinovaná $2 mesh $3 sllk_un_auth*d004359 $9 .
    675
      
    $a 616.857-085 $v 2. $z slo
    702
    -1
    $a Ramadan $b Nabih M. $3 sllk_un_auth*p0041990 $4 340
    712
    02
    $a American Academy of Neurology $3 sllk_un_auth*k0000007 $4 070
    801
    -0
    $a SK $b BA006 $c 20050701 $g AACR2

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.